How X-linked UTX affects natural killer cells differently in males and females
Sex Differences in NK Cells Mediated by X-linked UTX
This project explores why males and females respond differently to viral infections like human cytomegalovirus, focusing on how a specific gene on the X chromosome influences immune cells called natural killer cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11129875 on NIH RePORTER |
What this research studies
We know that males often get sicker from certain viral infections, like human cytomegalovirus, than females do. This difference might be due to how their immune systems work. Our work looks at natural killer (NK) cells, which are important for fighting viruses, and we've noticed that while males have more of these cells, they might not be as effective. We believe a gene on the X chromosome, called UTX, plays a key role in these differences by changing how NK cells develop and function. By understanding how UTX affects NK cells, we hope to uncover why immune responses vary between sexes.
Who could benefit from this research
Good fit: Patients interested in understanding sex-specific differences in immune responses to viral infections, particularly those with conditions related to natural killer cell function or viral susceptibility, might find this research relevant.
Not a fit: Patients seeking immediate new treatments or direct clinical interventions will not find direct benefit from this foundational biological research.
Why it matters
Potential benefit: This work could lead to new ways to boost the immune system and improve treatments for viral infections, especially for those who are more susceptible.
How similar studies have performed: While the concept of sex differences in immunity is recognized, this specific focus on the X-linked UTX gene's role in NK cell function represents a novel and promising area of investigation.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Su, Maureen a — University of California Los Angeles
- Study coordinator: Su, Maureen a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.